Global News

[ad_1] Carl Icahn Adam Jeffery | CNBC Biotech company Illumina pushed back Monday against Carl Icahn's proxy fight over the company's acquisition of cancer test developer Grail, saying the activist investor's board nominees "do not add value."  The San Diego-based DNA sequencing company released its latest response to Icahn's sharp criticism of the $7.1 billion deal it completed in 2021, saying it's committed to maximizing shareholder value as it works with antitrust regulators to "define GRAIL's path forward as expeditiously as possible." Icahn, who owns a 1.4% stake in Illumina, sent an open letter to the company's shareholders last week saying the DNA sequencing company paid too much for Grail and completed the "reckless" deal without getting European antitrust regulatory approval. He claimed those actions have wiped out $50 billion in Illumina's market value and "clearly shows that shareholders have lost fai

[ad_1] Microsoft signage is seen at the company's headquarters in Redmond, Washington, January 18, 2023. Matt Mills Mcknight | Reuters Check out the companies making the biggest moves midday: Zillow Group — Shares advanced nearly 4% after Evercore ISI upgraded the stock to outperform from in line, saying investors should buy shares ahead of what could be a " rapid recovery " in the housing market. The firm also boosted its price target to $61 from $34, suggesting about 44% upside from Friday's close. related investing news Microsoft — The technology corporation's shares rose more than 3% on Monday, pushing its market cap over $2 trillion once again, after Morgan Stanley reiterated its overweight rating for the stock. Microsoft announced its new AI-powered Bing search browser last week. Twilio — The cloud communication software marker gained 2.8% after announcing plans to cut 17% of its workforce , or roughly 1,500 jobs. Twilio already cut 11% of its workf